HARLOW Council has welcomed the decision that Harlow is to be the location for new £350m world-class public health labs which will create opportunities for local people and recognises Harlow as a major place in which to invest.
The investment in public health science announced by the Chancellor today (17 September 2015) will see part of Public Health England (PHE) move from its existing ageing facilities at Porton Down into the new labs at Harlow. This will continue PHE’s vital work in tackling some of the biggest issues in public health.
The new facilities, based on the site currently owned by GSK (GlaxoSmithKline) in the Pinnacles, will create a leading centre for research, health improvement and protection and allowing the continued development of world leading work on international health threats.
The new location in Harlow ensures Public Health England are well placed for collaborative work and engagement with a range of academia and the life sciences industry, with some of the best in the UK being based in the local area.
Councillor Jon Clempner, Leader of Harlow Council, said: “This is extremely good news for Harlow as it will increase the number of high quality science and research jobs and other job roles in the town. Harlow is at the heart of the London Cambridge Life Sciences corridor, and this will reinforce Harlow’s growing reputation as a science led town. It will also contribute to the Enterprise Zone developments in Harlow and the new world-class public health labs link perfectly with its MedTech focus, as well as increasing the attractiveness of the town for businesses in the science and health sector. We want the world’s best scientists and researchers to work here in Harlow but we also want to improve higher education and the educational and career opportunities for local people. Having world-class labs in Harlow will help to do just that.”
Popularity: 1% [?]